Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02142140Unknown
Randomised, open-label trial in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Attention Deficit Hyperactivity Disorder symptomatology at 27 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02142140.